ASHG 2026 · Diagnostics & clinical labs
LabCorp at ASHG 2026
Burlington, Vermont
LabCorp at ASHG 2026 in Montréal: 19 presentations (15 posters, 3 platform talks, 1 lightning talk); Booth 1024.
19
presentations on the program
3
Reviewers’ Choice abstracts
1024
exhibit booth
| Organization | ASHG 2026 Attendance |
|---|---|
LabCorp Burlington, Vermont | 1 Lab Director · 1 Senior Applied Research Scientist in Oncology · 1 Data scientist · 1 Statistical Geneticist · 4 other presenters |
Labcorp is a global leader of innovative and comprehensive laboratory services that helps doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions.
| Booth Exhibiting at Booth 1024 Wed, Oct 219:45am–4:30pmThu, Oct 229:45am–1:30pmFri, Oct 239:45am–4:30pm Talk Wed Oct 21 1:43 pm Poster Wed Oct 21 2:30 pm Diagnostic Yield and Clinical Utility of Genetic Testing in Unaffected Relatives with a Family History of Sudden Cardiac Death Genetic testingCardiovascular systemChannelopathiesClinical genetics Poster Wed Oct 21 2:30 pm Preoperative Lynch syndrome diagnosis and surgical outcomes in colorectal cancer: Evaluating resection extent, post-operative complications, and rates of metachronous and other cancers CancerGenetic testingPublic healthCancer syndromes Poster Wed Oct 21 2:30 pm Retrospective virtual panel modeling of carrier and high-risk couples detection by panel size in a large clinical reproductive carrier screening cohort Clinical testingGenetic counselingReproductive geneticsWomen's health Poster Wed Oct 21 2:30 pm ★ Reviewers’ Choice Sex-driven gaps in guideline-concordant follow-up after population genomic screening for hereditary cancer, cardiovascular, and metabolic conditionsGenetic testingCancer syndromesGenetic epidemiologyPrecision medicine Poster Wed Oct 21 2:30 pm From global calibration to gene-aware evidence: calibrating pathogenicity predictions for real-world variant interpretation Artificial intelligenceVariant interpretationMethodologyGenetic testing Poster Wed Oct 21 2:30 pm ★ Reviewers’ Choice Ancestry‑wide analysis of real‑world genomic testing reveals clinically relevant disparities in cancer prevalence, immunotherapy biomarkers, and variant actionabilityCancerClinical testingDiagnosticsEpidemiology Talk Thu Oct 22 8:15 am Closing the equity gap in variant classification: Machine learning-driven evidence demonstrates differential impact across race and ethnicity Computational toolsEthical, legal, and social implicationsGenetic testingMachine learning Talk Thu Oct 22 11:30 am Talk Thu Oct 22 2:15 pm Surveying the structural variant landscape in genetic testing: Prevalence and diagnostic yield in a clinical cohort of 1.8 million individuals Clinical geneticsCopy number/structural variationDiagnosticsGenetic testing Poster Thu Oct 22 4:15 pm ★ Reviewers’ Choice The impact of an iterative points-based framework on variant classification outcomes for neurodevelopmental disorders.Artificial intelligenceVariant interpretationNeurodevelopmentalClinical testing Poster Thu Oct 22 4:15 pm Applying Single Cell Transcriptomics and Machine Learning to Classify SCN1A Variants According to Disease Mechanism Laboratory genetics and genomicsGenomicsMachine learningGenetic variation Poster Thu Oct 22 4:15 pm A machine learning framework for accurate SMN1 copy number determination from short-read next-generation sequencing data BioinformaticsCopy number/structural variationGenomicsMachine learning Poster Thu Oct 22 4:15 pm Biochemical data and genetic testing: combining datasets to help classify variants Laboratory genetics and genomicsVariant interpretationPhenotypeMetabolic disorder Poster Fri Oct 23 2:30 pm Assessment of Structural and Copy Number Variants in Constitutional Samples Using Electronic Genome Mapping AneuploidyChromosomal abnormalitiesClinical testingCopy number/structural variation Poster Fri Oct 23 2:30 pm Validating gain- and loss-of-function multiplexed assay of variant effect (MAVE) predictions using linked genetic testing and biochemical datasets: a CASR case study Variant interpretationGenotype-phenotype correlationsMendelian disorderRare variants Poster Fri Oct 23 2:30 pm Evidence supporting RPS20 as a colorectal cancer susceptibility gene from a case-control study CancerCancer syndromesGenetic epidemiologyGenetic testing Poster Fri Oct 23 2:30 pm A conversational AI agent for multi-domain clinicogenomic research analytics with layered human-in-the-loop verification Artificial intelligenceComputational toolsDatabasesGenotype-phenotype correlations Poster Fri Oct 23 2:30 pm Single-cell transcriptomic variant effect mapping of clinically relevant MSH3 variants Machine learningMassively parallel sequencingVariant interpretation |
Meeting LabCorp in Montréal?
Get in-depth attendee and institution profiles and research, to plan your meetings in Montréal. Leave your work email and we’ll be in touch.
Not affiliated with or endorsed by the American Society of Human Genetics. Submit a correction